相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Drug Titration Paradox: Correlation of More Drug With Less Effect in Clinical Data
Thomas W. Schnider et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Precision Dosing: An Industry Perspective
Richard W. Peck
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Supporting Precision Dosing in Drug Labeling
Michael Neely et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Development and Implementation of Electronic Health Record-Integrated Model-Informed Clinical Decision Support Tools for the Precision Dosing of Drugs
Alexander A. Vinks et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Use of Titration as a Therapeutic Individualization Strategy: An Analysis of Food and Drug Administration-Approved Drugs
Robert N. Schuck et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2019)
The remarkable therapeutic potential of response-based dose individualisation in drug trials and patient care
Chao Chen
DRUG DISCOVERY TODAY (2018)
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies et al.
DIABETES CARE (2018)
Comparison of the pharmacokinetic and pharmacodynamic profiles of insulin degludec and insulin glargine
Tim Heise et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)
Clinical pharmacology = disease progression plus drug action
Nick Holford
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Establishing Good Practices for Exposure-Response Analysis of Clinical Endpoints in Drug Development
R. V. Overgaard et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2015)
Dose-response relationship from longitudinal data with response-dependent dose modification using likelihood methods
Ikuko Funatogawa et al.
BIOMETRICAL JOURNAL (2012)
Ultra-long-acting insulin degludec has a flat and stable glucose-lowering effect in type 2 diabetes
T. Heise et al.
DIABETES OBESITY & METABOLISM (2012)
The challenges of evaluating dose response in flexible-dose trials using marginal structural models
Ilya Lipkovich et al.
PHARMACEUTICAL STATISTICS (2012)
Analysis of dose-response in flexible dose titration clinical studies
Xu (Steven) Xu et al.
PHARMACEUTICAL STATISTICS (2012)
Evaluating dose response from flexible dose clinical trials
Ilya Lipkovich et al.
BMC PSYCHIATRY (2008)
The treat-to-target trial - Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
MC Riddle et al.
DIABETES CARE (2003)
分享论文
